In ME/CFS patients, plasma levels of anti-β-LGB, ZO-1, LPS, and sCD14 were significantly higher than in controls (P < 0.01), but lower than in FM cases (P < 0.001). This evidence concerns the gene TJP1 and myalgic encephalomeyelitis/chronic fatigue syndrome.